# Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

> **NCT06782412** · PHASE2,PHASE3 · RECRUITING · sponsor: **KU Leuven** · enrollment: 109 (estimated)

## Conditions studied

- Oesophageal Cancer
- Gastric Cancer
- Pancreatic Ductal Adenocarcinoma
- FAP
- Oncology
- Oncologic Disorders

## Interventions

- **DIAGNOSTIC_TEST:** [18F]AlF-FAPI-74 PET/CT

## Key facts

- **NCT ID:** NCT06782412
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-06
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 109 (ESTIMATED)
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782412, "Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06782412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*